RG
BEAT

Renaissance Group’s BioTelemetry, Inc. BEAT Stock Holding History

Renaissance Group’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-16,009
Closed -$730K – 291
2020
Q3 		$730K Sell
16,009
-129
-0.8% -$5.39K 0.03% 163
2020
Q2 		$729K Buy
16,138
+143
+0.9% +$6.41K 0.03% 157
2020
Q1 		$616K Buy
15,995
+1,633
+11% +$75.2K 0.03% 155
2019
Q4 		$665K Buy
14,362
+6,270
+77% +$272K 0.03% 218
2019
Q3 		$330K Sell
8,092
-17
-0.2% -$734 0.01% 234
2019
Q2 		$390K Sell
8,109
-101
-1% -$5.31K 0.02% 230
2019
Q1 		$514K Sell
8,210
-1,209
-13% -$83K 0.02% 205
2018
Q4 		$563K Buy
+9,419
New +$566K 0.03% 173
2017
Q4 		– Sell
-12,407
Closed -$409K – 308
2017
Q3 		$409K Buy
12,407
+2
+0% +$69 0.01% 209
2017
Q2 		$415K Buy
12,405
+301
+2% +$8.98K 0.02% 181
2017
Q1 		$350K Sell
12,104
-4,219
-26% -$105K 0.01% 209
2016
Q4 		$365K Sell
16,323
-920
-5% -$18K 0.01% 188
2016
Q3 		$320K Buy
+17,243
New +$325K 0.01% 204

Other funds holding BEAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
GL
Governors Lane New York $1.2B AUM 26.21% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $383M AUM 123.08% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return

Renaissance Group's BEAT Position: Q4 2020 in Review

Renaissance Group sold out of BioTelemetry, Inc. (BEAT) in Q4 2020, closing a stake of 16,009 shares — an estimated $730K sold.

Renaissance Group first reported a position in BEAT in Q3 2016 and held it in 13 quarters. The position peaked at $730K in Q3 2020. 238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.

  • Renaissance Group reported no remaining BioTelemetry, Inc. position as of Q4 2020 after selling out during the quarter.
  • Renaissance Group sold 16,009 BioTelemetry, Inc. shares in Q4 2020, an estimated $730K.
  • Renaissance Group first reported a position in BioTelemetry, Inc. in Q3 2016 and held it in 13 quarters.
  • Renaissance Group's BioTelemetry, Inc. position peaked at $730K in Q3 2020.
  • 238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.

Based on Renaissance Group's 13F filing for Q4 2020, filed 12 Feb 2021.